Cannabis Legalization News
500 episodes listed below
PRESS PLAY
🌿✨ "Cannabis Legalization News" 🌿✨ - Dive into the latest on cannabis laws with hosts Tom & Miggy, Illinois dispensary owners! 🎙️ Each episode, we unpack state regulations, discuss impacts on consumers & businesses, and share expert tips on navigating the cannabis legal scene. 📈🌱Join us for lively chats with industry leaders, policymakers, and legal pros. 🌟 Whether you're in the biz, curious about your rights, or following cannabis trends, we've got you covered. 📚🔍Stay informed, compliant, and ahead of the curve. Subscribe for your regular dose of cannabis clarity! 🎧 #CannabisNews #LegalizeIt #CannabisCommunity
Based on 6 episodes we listened to · June 2026
A cannabis policy show that turns reclassification, hemp law, licensing, and access fights into practical civic context.
Cannabis Legalization News Podcast sits on the politics and policy edge of the cannabis beat, treating the subject as law, business, medicine, and culture at the same time.
You want cannabis policy explained by someone pricing the compliance headache in real time.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A loose but readable look at cannabis law, hemp, and the real fights still playing out in several states.
The episode starts with a Supreme Court angle on the Second Amendment and marijuana use, then opens out into cannabis legalization stories across the United States.
A clear look at a Massachusetts challenge to federal marijuana prohibition through Gonzalez v. Raich.
The episode centers on a Massachusetts challenge to federal marijuana prohibition, with Gonzalez v. Raich as the legal anchor and fully licensed, fully regulated, intrastate operators seeking relief from the Supreme Court.
A noisy but legally sharp run through the week's cannabis fights.
This episode takes Trump's Tuesday-night State of the Union as a starting point and stays with the practical side of cannabis politics, hemp rules, and the gap between federal policy and state reality.
A blunt, fast-moving pass through cannabis policy news.
It moves quickly through cannabis policy news, with the DOJ push on rescheduling into 2026, Trump’s posts about med beds and weed, Nebraska regulators saying they may have overstepped, and Texas hemp still working its way through the system.
Cannabis policy and chemistry meet in a practical, easygoing conversation.
Cannabis legalization sits in the background while the episode narrows in on CHS and the practical science around it. Riley walks through a survey of just over a thousand people who said they had been diagnosed with CHS or told they had CHS, then moves through consumption…
A blunt, useful take on how cannabis policy, taxes, and interstate limits are colliding.
HEMP BAN FREAK-OUT is a state-by-state look at cannabis policy with real commercial consequences. It moves from tax treatment and banking friction to beverage rules and interstate limits, and it is strongest when it keeps the focus on what the law permits rather than what the…
A loose, practical look at cannabis market structure, consolidation, and local operators.
The episode keeps its focus on cannabis legalization and market structure, and the pharmacy comparison works because it makes the regulatory burden feel tangible. The dispensary examples help too.
A deadline episode that turns hemp policy into a blunt lesson about definitions, enforcement, and market reality.
An episode about the federal hemp deadline lands in the middle of the state-by-state mess that now defines cannabis policy. The hosts keep coming back to the FDA's February 10 clock, the THCA dispute, and the gap between what regulators say and what the market is already doing.
Cannabis policy, live from the legal weeds.
Sam Harris interviews scientists and journalists on AI risk, religion, and US politics.
WSJ reporters unpack the Epstein files, surrogacy industry abuses, and true-crime court battles.
Kara Swisher and Scott Galloway argue through tech, media, and Trump-era politics twice weekly.
Dan Carlin's solo essays connecting executive power, historical collapse, and American democracy.
Sharp political debate with policy detail and real disagreement.
Hosts Tom and Miggy discuss major cannabis news, including IRS tax issues under 280E, rescheduling to Schedule III, and state updates like Texas banning smokable hemp and Virginia's new licensing.
Cannabis Legalization News spends this episode on the hemp rule change, saying the new federal definition reclassifies hemp as non-psychoactive cannabis and closes the THCA-style loophole.
Cannabis Legalization News opens on a February 23rd Farm Bill markup and says the new House Agriculture draft keeps hemp at 0.3% total THC while pushing gummies, sodas, and vapes toward FDA jurisdiction.
Hosts Tom and Miggy discuss the recent executive order to reclassify cannabis to Schedule III, covering its implications for taxes, state laws, and businesses.
Hosts Tom and Miggy interview Dr.
The show opens on a federal-law-heavy week and makes clear it is not treating the mess as simple.
It opens with a reset of the show's 2026 predictions.
Hemp is not legalization—it was a loophole the industry exploited, and only medical cannabis has driven real policy forward.
Canvas Legalization News covers federal policy momentum with congressional legalization efforts and Trump nominee questioning, geopolitical context as Spain moves toward medical legalization, retail milestone with Target's THC drinks, and state-level governor responses to hemp-derived cannabinoid loopholes.
Hosts discuss major cannabis policy developments: the DOJ's decision to delay rescheduling until 2026, Trump's cryptic tweets about CBD and med beds causing stock spikes, federal government shutdown impacts, and state regulatory confusion (particularly Nebraska hemp overreach).
The FDA is on the clock.
The show opens with housekeeping and a newsletter plug.
The show opens with the Supreme Court taking up a Second Amendment question tied to people who own and regularly use marijuana.
Cannabis Legalization News centers on the CLIMB Act, a bipartisan bill that would let cannabis companies list on NASDAQ or the New York Stock Exchange, while Tom and Miggy say the legislation still does not fix the underlying legal framework.
Cannabis Legalization News Podcast centers this episode on the NRA joining a cannabis-side brief in a Supreme Court case over whether marijuana users can possess firearms.
Idaho is singled out as the clearest 2026 legalization state to watch, while Alaska, Massachusetts, Missouri, Nebraska, and Washington are also mentioned as possible ballot-measure states.
The episode breaks down Supreme Court oral arguments in the cannabis-users Second Amendment case under 18 U.S.C.
Seven years of Canadian legalization with zero apocalypse.
Tom Howard of Cannabis Legalization News says a leaked White House summary points to Donald Trump directing the Attorney General to expedite cannabis to Schedule 3 and urging Congress to update hemp definitions.
Cannabis Legalization News Podcast focuses on SCOTUS review of Canna Provisions v.
Hosts Tom and Miggy, Illinois dispensary owners, discuss US cannabis rescheduling delays and Chinese money laundering in lax states, then interview Dave Barton from the UK about their struggling medical cannabis program with only 60,000 patients.
The show opens with hemp losing its last-minute bid to buy time by tying itself to the possible shutdown deal.
The hosts open with Donald Trump’s State of the Union and what they say was left out of it.
Hosts discuss recent cannabis legalization rulings in Texas and Ohio, White House delays on Schedule 3, and industry news.
A news roundup covering recent bad news in cannabis policy, including a Texas hemp executive order and DOJ rule withdrawals, with commentary and analysis.
This episode covers the latest cannabis legalization news, focusing on federal policy changes including Schedule 3 and Trump's stance, with a guest discussion on implications.
Hosts discuss cannabis legalization news, including an interview at CannaCon with a former prosecutor turned industry advocate.